• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种酞菁光敏剂细胞摄取过程中光动力功效的变化

Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers.

作者信息

He J, Horng M F, Deahl J T, Oleinick N L, Evans H H

机构信息

Division of Radiation Biology, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4942, USA.

出版信息

Photochem Photobiol. 1998 Jun;67(6):720-8.

PMID:9648537
Abstract

A decrease in the efficacy of photodynamic therapy (PDT) with phthalocyanine photosensitizers was observed for lymphoblastic murine and human cell lines as the time between the addition of the photosensitizer, aluminum phthalocyanine (AIPc), to the culture medium and exposure to light was increased from 4 h to 18 h. The total intracellular concentration of photosensitizer did not decrease significantly during this 18 h interval. For the murine cell lines, the maximum cytotoxic and mutagenic effects were observed when the time between addition of the photosensitizer and irradiation was between 1 and 4 h. The time course of the variations in efficacy did not vary greatly from one murine cell line to another, even though the cell lines differ markedly in the extent of their cytotoxic and mutagenic response. The time course of the variation was similar for cytotoxicity and mutagenicity, as well as for the induction of DNA fragmentation. The human lymphoblastic cell line, WTK1, showed less variation in survival and mutability with time than did the murine cell lines. With Pc 4 (HOSiPcOSi[CH3]2[CH2]3N[CH3]2) as the photosensitizer, the photocytotoxicity for murine L5178Y (LY)-S1 cells did not change significantly as the time between addition of Pc 4 and irradiation was increased from 2 to 18 h. However, the mutagenicity decreased by a factor of three during this interval. The mutagenicity of PDT with Pc 4 was much less in LY-S1 cells than that with AlPc. The results suggest that the variation in the efficacy observed for AlPc-induced photocytotoxicity is caused by changes in the intracellular distribution and/or the aggregation of the photosensitizer with time after its addition.

摘要

随着向培养基中添加铝酞菁(AIPc)光敏剂后至光照的时间从4小时增加到18小时,在小鼠和人类淋巴细胞系中观察到酞菁光敏剂的光动力疗法(PDT)疗效下降。在此18小时期间,光敏剂的细胞内总浓度没有显著降低。对于小鼠细胞系,当添加光敏剂和照射之间的时间在1至4小时之间时,观察到最大的细胞毒性和诱变作用。尽管细胞系在细胞毒性和诱变反应程度上有显著差异,但从一个小鼠细胞系到另一个细胞系,疗效变化的时间进程差异不大。细胞毒性、诱变性以及DNA片段化诱导的变化时间进程相似。与小鼠细胞系相比,人类淋巴细胞系WTK1的存活率和变异性随时间的变化较小。以Pc 4(HOSiPcOSi[CH3]2[CH2]3N[CH3]2)作为光敏剂,当添加Pc 4和照射之间的时间从2小时增加到18小时时,对小鼠L5178Y(LY)-S1细胞的光细胞毒性没有显著变化。然而,在此期间诱变性降低了三倍。LY-S1细胞中Pc 4介导的PDT的诱变性远低于AlPc。结果表明,观察到的AlPc诱导的光细胞毒性疗效变化是由添加光敏剂后其细胞内分布和/或聚集随时间的变化引起的。

相似文献

1
Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers.两种酞菁光敏剂细胞摄取过程中光动力功效的变化
Photochem Photobiol. 1998 Jun;67(6):720-8.
2
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.在无胸腺小鼠中,用酞菁光敏剂Pc 4对SW480人结肠癌异种移植瘤进行光动力治疗。
Clin Cancer Res. 2000 May;6(5):2021-7.
3
Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.人鳞状细胞癌的体外光动力疗法及裸鼠异种移植瘤光动力疗法
Laryngoscope. 1993 Sep;103(9):967-75. doi: 10.1288/00005537-199309000-00005.
4
Association of ceramide accumulation with photodynamic treatment-induced cell death.神经酰胺积累与光动力治疗诱导的细胞死亡之间的关联。
Photochem Photobiol. 1998 Jul;68(1):101-9.
5
Photodynamic activities of silicon phthalocyanines against achromic M6 melanoma cells and healthy human melanocytes and keratinocytes.
J Photochem Photobiol B. 1999 Jan;48(1):48-56. doi: 10.1016/S1011-1344(99)00008-1.
6
Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis.以锌(II)酞菁作为开关在细胞凋亡和坏死之间做出抉择的光敏作用。
Cancer Res. 2001 Oct 15;61(20):7495-500.
7
Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.用二磺酸铝酞菁或光敏素进行光动力疗法导致EMT-6肿瘤坏死的不同机制的证据:肿瘤细胞存活和血流
Anticancer Res. 1996 Jul-Aug;16(4A):1887-92.
8
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.酞菁4(Pc 4)对人卵巢癌细胞系OVCAR-3移植瘤的光动力治疗
Photochem Photobiol. 1999 Feb;69(2):236-41.
9
Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.用于光动力疗法的水溶性铝酞菁-聚合物缀合物:荷瘤小鼠的光动力活性和药代动力学
Br J Cancer. 1999 Jul;80(10):1533-41. doi: 10.1038/sj.bjc.6690557.
10
Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.利用内化单克隆抗体靶向四磺酸铝(III)酞菁:光动力疗法中疗效的改善
Cancer Res. 2001 Mar 1;61(5):1970-5.